EDELRIS is a pioneering company dedicated to the design and chemical synthesis of innovative natural product-like screening Libraries, Hit-to-Lead / Lead Optimization projects, Custom Synthesis, and Affinity screening-Mass Spectrometry (AS-MS). Aiming at the acceleration of the lead discovery and optimization process in pharma and biotech research organizations, EDELRIS uses its recognized chemistry and screening expertise in drug discovery to provide novelty to its customers. Our unique and first-in-class NP-like, easily tractable screening libraries (Fragments, Compounds & DEL) now contains 2M in-house synthesized compounds, with built-in hit-to-lead optimization capabilities. These libraries can be reviewed by our clients on an exclusive- or non-exclusive basis. EDELRIS has a wide range of services and provides state-of-the-art target qualification (protein and RNAs), screening and hit identification capacities by applying our in-house AS-MS (Affinity Selection – Mass Spectrometry) technologies. We dispose a considerable chemical analysis department in support to our broad portfolio of ongoing organic, parallel and medicinal chemistry projects. The EDELRIS-team is capable to deliver innovative solutions to synthetic and medicinal chemistry challenges faced by our clients. When partnering with EDELRIS, we focus our effort to create value for your projects.